Plitidepsin in patients with advanced colorectal cancer (CRC): Results of an exploratory phase II trial

被引：0
|
作者：
Tabernero, Josep M.
Rivera, Fernando
Casado, Esther
Sanchez, Antonio
Bezares, Susana
Pico, Cesar
Paz-Ares, Luis
机构：
[1] Hosp Gen Valle Hebron, Barcelona, Spain
[2] Univ Marques Valdecilla, Santander, Spain
[3] Clin Puerta Hierro, Madrid, Spain
[4] PharmaMar SAU, Madrid, Spain
[5] Univ Madrid, Hosp 12 Octubre, Madrid 3, Spain
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：122 / 122
页数：1
相关论文
共 50 条
  • [31] PHASE-II TRIAL OF MAYTANSINE IN PATIENTS WITH ADVANCED COLORECTAL CARCINOMA
    OCONNELL, MJ
    SHANI, A
    RUBIN, J
    MOERTEL, CG
    CANCER TREATMENT REPORTS, 1978, 62 (08): : 1237 - 1238
  • [32] FOLFOX / Bevacizumab (Beva) plus /- Irinotecan in advanced colorectal cancer (CRC): A randomized phase II trial (AIO KRK 0209, CHARTA)
    Schmoll, H. J.
    Garlipp, B.
    Junghanss, C.
    Leithauser, M.
    Vogel, A.
    Schaefers, M.
    Kaiser, U.
    Hoeffkes, H. G.
    Florschuetz, A.
    Ruessel, J.
    Kanzler, S.
    Edelmann, T.
    Forstbauer, H.
    Goehler, T.
    Hannig, C.
    Hildebrandt, B.
    Steighardt, J.
    Meinert, F. M.
    Cygon, F.
    Stein, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [33] Phase II trial of edatrexate in patients with metastatic colorectal cancer
    Clamon, GH
    Riggs, CE
    Dreicer, R
    Hohl, RJ
    INVESTIGATIONAL NEW DRUGS, 1995, 13 (04) : 359 - 361
  • [34] Results of a Phase II Trial of Cetuximab plus Capecitabine/Irinotecan as First-Line Therapy for Patients with Advanced and/or Metastatic Colorectal Cancer
    Cartwright, Thomas
    Kuefler, Paul
    Cohn, Allen
    Hyman, William
    Berger, Maury
    Richards, Donald
    Vukelja, Svetislava
    Nugent, John E.
    Ruxer, Robert L., Jr.
    Boehm, Kristi A.
    Asmar, Lina
    CLINICAL COLORECTAL CANCER, 2008, 7 (06) : 390 - 397
  • [35] Phase II trial of capecitabine plus erlotinib versus capecitabine alone in patients with advanced colorectal cancer
    Vincent, Mark D.
    Breadner, Daniel
    Soulieres, Denis
    Kerr, Ian G.
    Sanatani, Michael
    Kocha, Walter
    Klimo, Peter
    MacKenzie, Mary J.
    O'Connell, Anne
    Whiston, Frances
    Malpage, Anne S.
    Stitt, Larry
    Welch, Stephen A.
    FUTURE ONCOLOGY, 2017, 13 (09) : 777 - 786
  • [36] Phase I/II trial of dose-reduced capecitabine in elderly patients with advanced colorectal cancer
    Vincent, M. D.
    Breadner, D.
    Cripps, M. C.
    Jonker, D. J.
    Klimo, P.
    Biagi, J. J.
    Lam, W.
    O'Connell, A.
    Whiston, F.
    Stitt, L.
    Welch, S. A.
    CURRENT ONCOLOGY, 2017, 24 (04) : E261 - E268
  • [37] PHASE-II TRIAL OF 10-DEAZA-AMINOPTERIN IN PATIENTS WITH ADVANCED COLORECTAL-CANCER
    CHENG, EW
    CURRIE, VE
    YAGODA, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (04): : 469 - 471
  • [38] Phase I/II trial of autologous activated macrophages in advanced colorectal cancer
    Eymard, JC
    Lopez, M
    Cattan, A
    Bouche, O
    Adjizian, JC
    Bernard, J
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (11) : 1905 - 1911
  • [39] PHASE-II TRIAL OF IFOSFAMIDE AND MESNA IN ADVANCED COLORECTAL-CANCER
    KEMENY, N
    REICHMAN, B
    DOUGHERTY, J
    LIPPERMAN, R
    CHENG, E
    CANCER TREATMENT REPORTS, 1987, 71 (06): : 663 - 664
  • [40] PHASE-II TRIAL OF UFT IN ADVANCED COLORECTAL AND GASTRIC-CANCER
    MALIK, STA
    TALBOT, D
    CLARKE, PI
    OSBORNE, R
    REZNEK, R
    WRIGLEY, PFM
    SLEVIN, ML
    BRITISH JOURNAL OF CANCER, 1990, 62 (06) : 1023 - 1025
12345